drugset
drugset / Trial / NCT00581451

Study Evaluating the Tolerability of Bifeprunox in Healthy Subjects

NCT00581451 ↗

Phase 1 Completed 144 enrolled Wyeth is now a wholly owned subsidiary of Pfizer
RandomizedSingle-groupTriple-blind

Summary

Safety and tolerability study in healthy volunteers

Timeline

Start
2007-10
Primary completion
2008-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Bifeprunox Small molecule — Oral

Indications

No indication recorded.